STUDIES ON THE MECHANISM OF ACTION OF 6-MERCAPTOPURINE (6MP) IN CELL-FREE PREPARATIONS

被引：0
|
作者：
SALSER, JS
BALIS, ME
机构：
来源：
FEDERATION PROCEEDINGS | 1959年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [21] The multicenter, pediatric Crohn's disease (CD) 6-mercaptopurine(6MP) trial: Final results.
    Markowitz, J
    Grancher, K
    Kohn, N
    Daum, F
    GASTROENTEROLOGY, 1999, 116 (04) : A771 - A771
  • [22] Prognostic importance of dose intensity of 6-mercaptopurine (6MP) therapy in childhood acute lymphoblastic leukemia (ALL).
    Relling, MV
    Hancock, ML
    Boyett, JM
    Pui, CH
    Evans, WE
    BLOOD, 1998, 92 (10) : 482A - 483A
  • [23] A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol
    Shibani Nicum
    Corran Roberts
    Lucy Boyle
    Sylwia Kopijasz
    Charlie Gourley
    Marcia Hall
    Ana Montes
    Christopher Poole
    Linda Collins
    Anna Schuh
    Susan J Dutton
    BMC Cancer, 14
  • [24] Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours
    Corran Roberts
    Victoria Y. Strauss
    Sylwia Kopijasz
    Charlie Gourley
    Marcia Hall
    Ana Montes
    Jacinta Abraham
    Andrew Clamp
    Richard Kennedy
    Susana Banerjee
    Lisa K. Folkes
    Michael Stratford
    Shibani Nicum
    British Journal of Cancer, 2020, 122 : 483 - 490
  • [25] STUDIES ON THE MECHANISM OF ACTION OF 6-MERCAPTOPURINE - INTERACTION WITH COPPER AND XANTHINE-OXIDASE
    KELA, U
    VIJAYVARGIYA, R
    BIOCHEMICAL JOURNAL, 1981, 193 (03) : 799 - 803
  • [26] A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol
    Nicum, Shibani
    Roberts, Corran
    Boyle, Lucy
    Kopijasz, Sylwia
    Gourley, Charlie
    Hall, Marcia
    Montes, Ana
    Poole, Christopher
    Collins, Linda
    Schuh, Anna
    Dutton, Susan J.
    BMC CANCER, 2014, 14
  • [27] STUDIES ON ANTI-INFLAMMATORY ACTION OF 6-MERCAPTOPURINE
    HURD, ER
    ZIFF, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 1968, 128 (04): : 785 - &
  • [28] Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours
    Roberts, Corran
    Strauss, Victoria Y.
    Kopijasz, Sylwia
    Gourley, Charlie
    Hall, Marcia
    Montes, Ana
    Abraham, Jacinta
    Clamp, Andrew
    Kennedy, Richard
    Banerjee, Susana
    Folkes, Lisa K.
    Stratford, Michael
    Nicum, Shibani
    BRITISH JOURNAL OF CANCER, 2020, 122 (04) : 483 - 490
  • [29] ABOLITION OF IMMUNOLOGIC MEMORY WITH 6-MERCAPTOPURINE (6-MP)
    FORSEN, NR
    CONDIE, RM
    FEDERATION PROCEEDINGS, 1963, 22 (02) : 500 - &
  • [30] The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX)
    Giverhaug, T
    Loennechen, T
    Aarbakke, J
    GENERAL PHARMACOLOGY, 1999, 33 (04): : 341 - 346
12345